Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 15, Issue 7, 1995, Pages 963-971

  Clavey, V ^a,b   Lestavel Delattre, S ^a,b   Copin, C ^b   Bard, J M ^b   Fruchart, J C ^a,b  

^a UNIV LILLE   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

apolipoproteins; LDL receptor; lipoprotein B; triglyceride enrichment

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; BINDING AFFINITY; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PURIFICATION; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0029018057     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.15.7.963     Document Type: Article

References (31)

1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
2. Milne R, Theolis R Jr, Maurice R, Pease RJ, Weech PK, Rassart E, Fruchart JC, Scott J, Marcel YL. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J Biol Chem. 1989;264:19754-19760.
3. Hospattankar AV, Law SW, Lackner K, Brewer HB Jr. Identification of low density lipoprotein receptor binding domains of human apolipoprotein B100: a proposed consensus LDL receptor binding sequence of apo B100. Biochem Biophys Res Commun. 1986;139:1078-1085.
4. Fantappié S, Corsini A, Sidoli A, Uboldi P, Granata A, Zanelli T, Rossi P, Marcovina S, Fumagalli R, Catapano AL. Monoclonal antibodies to human low density lipoprotein identify distinct areas on apolipoprotein B100 relevant to the low density lipoprotein receptor interaction. J Lipid Res. 1992;33:1111-1121.
5. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apo B100. Proc Natl Acad Sci U S A. 1989;86:587-591.
6. Marcel YL, Innerarity TL, Spilman C, Mahley RW, Protter AA, Milne RW. Mapping of human apolipoprotein B antigenic determinants. Arteriosclerosis. 1987;7:166-175.
7. Aviram M, Lundkatz S, Phillips MC, Chait R. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B100 with cells. J Biol Chem. 1988;263:16842-16848.
8. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res. 1991;32: 1741-1753.
9. Bradley WA, Hwang SC, Karlin JB, Lin AH, Prasad SC, Gotto AM, Gianturco SH. Low density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very low density lipoproteins to low density lipoproteins. J Biol Chem. 1984;259:14728-14735.
10. Bradley WA, Gianturco SH. Apo E is necessary and sufficient for the binding of large triglyceride-rich lipoprotein to the LDL receptor: apo B is unnecessary. J Lipid Res. 1986;27:40-48.
11. Agnani G, Bard JM, Candelier L, Delattre S, Fruchart JC, Clavey V. Interaction of LpB, LpB:E, LpB:C-III and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler Thromb. 1991;11:1021-1029.
12. Sehayek E, Eisenberg S. Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism. Arterioscler Thromb. 1990;10:1088-1096.
13. Evans AJ, Huff MH, Wolfe BM. Accumulation of an apo E-poor subfraction of very low density lipoprotein in hypertriglyceridemic men. J Lipid Res. 1989;30:1691-1701.
14. Eisenberg S, Friedman G, Vogel T. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3. Arteriosclerosis. 1988;8:480-487.
15. Sehayek E, Eisenberg S. Mechanism of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem. 1991;266:18258-18267.
16. Bard JM, Candelier L, Agnani G, Clavey V, Torpier G, Steinmetz A, Fruchart JC. Isolation and characterization of human LpB lipoprotein containing apolipoprotein B as the sole apolipoprotein. Biochim Biaphys Acta. 1991;1082:170-176.
17. 2 and E from human plasma. J Chromatogr B Biomed Appl. 1987;414:35-45.
18. Rall SC, Weisgraber KH, Mahley RW. Isolation and characterization of apolipoprotein E. Methods Enzymol. 1986;128:273-287.
19. Menzel HJ, Uterman G. Apolipoprotein E phenotyping from serum Western blotting. Electrophoresis. 1986;7:492-495.
20. Mezdour H, Vu Dac N, Parra HJ, Luc G, Luycye I, Fruchart JC. A selective bisite immunoenzymometric procedure for human Lp(a) particle quantification using monoclonal antibodies against apo (a) and apo B. J Lipid Res. 1989;30:1437-1443.
21. Fruchart JC, Fievet C, Puchois P. Methods of enzymatic analysis: apolipoproteins. Bergmeyer 3rd ed. Weinheim, FRG: Verlag, Chemie; 1985:126-138.
22. Petersen GL. A simplification of the protein assay method of Lowry which is more generally applied. Anal Biochem. 1977;83:343-356.
23. Granot E, Deckelbaum RJ, Eisenberg S, Oschry Y, Bengtsson-Olivecrona G. Core modification of human low density lipoprotein by artificial triacylglycerol emulsion. Biochim Biophys Acta. 1985;833:308-315.
24. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins. Biochim Biophys Acta. 1972;260:212-221.
25. McConahey PJ, Dixon FJ. Radioiodination of proteins by the use of the chtoramine-T method. Methods Enzymol. 1980;70:210-213.
26. Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974;249:5153-5162.
27. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76: 4350-4354.
28. Granot E, Schwiegelshohn B, Tabas I, Gorecki M, Vogel T, Carpentier YA, Deckelbaum RJ. Effects of particle size on cell uptake of model triglyceride-rich particles with and without apoprotein E. Biochemistry. 1994;33:15190-15197.
29. Deckelbaum RJ, Shipley GG, Small DM. Structure and interactions of lipids in human plasma low density lipoproteins. J Biol Chem. 1977;252:744-752.
30. Galeano NF, Rumsey SC, Preud'Homme DL, Gleeson A, Deckelbaum RJ. Small LDL from hypertriglyceridemic subjects have increased non-LDL receptor low density affinity cell binding. Circulation. 1993;88(suppl I):I-366. Abstract.
31. Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson D, Norum R, Brown WV. Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein C-III and A-I. J Clin Invest. 1986;78:1287-1295.